Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab

DOI: 10.1080/2162402X.2018.1452581

Keywords: nivolumab, non-small cell lung cancer, plasma, PD-L1, PD-L2, Granzyme B, Interleukine-2, Interferon-γ, microRNA, plasma, biomarker

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text